James N. Frame

1.4k total citations
41 papers, 995 citations indexed

About

James N. Frame is a scholar working on Oncology, Surgery and Hematology. According to data from OpenAlex, James N. Frame has authored 41 papers receiving a total of 995 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 9 papers in Surgery and 7 papers in Hematology. Recurrent topics in James N. Frame's work include Heparin-Induced Thrombocytopenia and Thrombosis (8 papers), Venous Thromboembolism Diagnosis and Management (5 papers) and Pharmacogenetics and Drug Metabolism (4 papers). James N. Frame is often cited by papers focused on Heparin-Induced Thrombocytopenia and Thrombosis (8 papers), Venous Thromboembolism Diagnosis and Management (5 papers) and Pharmacogenetics and Drug Metabolism (4 papers). James N. Frame collaborates with scholars based in United States, United Kingdom and Canada. James N. Frame's co-authors include Robin Zoň, Donald T. Moir, Neil E. Caporaso, Bruce E. Johnson, Daniel C. Ihde, Barbara Weiffenbach, Dana S. Wollins, D. Vena, John M. Sorensen and Linda D. Bosserman and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Internal Medicine.

In The Last Decade

James N. Frame

40 papers receiving 959 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James N. Frame United States 17 329 263 171 164 161 41 995
Sidney Scudder United States 20 603 1.8× 316 1.2× 101 0.6× 406 2.5× 156 1.0× 49 1.9k
Clarence Lam China 19 364 1.1× 346 1.3× 245 1.4× 207 1.3× 101 0.6× 42 1.4k
Finn Wesenberg Norway 28 219 0.7× 165 0.6× 738 4.3× 243 1.5× 87 0.5× 87 2.2k
G. Aulagner France 18 119 0.4× 141 0.5× 240 1.4× 126 0.8× 112 0.7× 79 1.2k
Janine Ross United Kingdom 14 204 0.6× 159 0.6× 102 0.6× 173 1.1× 109 0.7× 24 1.1k
R. Jackson Forcier United States 11 427 1.3× 133 0.5× 112 0.7× 207 1.3× 149 0.9× 18 785
L. Tagliabue Italy 13 489 1.5× 260 1.0× 294 1.7× 151 0.9× 61 0.4× 22 1.3k
Daryn Smith United States 20 327 1.0× 293 1.1× 85 0.5× 321 2.0× 122 0.8× 64 1.1k
John J. Stuart United States 22 457 1.4× 223 0.8× 266 1.6× 155 0.9× 86 0.5× 51 1.3k
Eleanor Kane United Kingdom 19 541 1.6× 74 0.3× 237 1.4× 398 2.4× 150 0.9× 49 1.7k

Countries citing papers authored by James N. Frame

Since Specialization
Citations

This map shows the geographic impact of James N. Frame's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James N. Frame with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James N. Frame more than expected).

Fields of papers citing papers by James N. Frame

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James N. Frame. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James N. Frame. The network helps show where James N. Frame may publish in the future.

Co-authorship network of co-authors of James N. Frame

This figure shows the co-authorship network connecting the top 25 collaborators of James N. Frame. A scholar is included among the top collaborators of James N. Frame based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James N. Frame. James N. Frame is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Basch, Ethan, D.A. Loblaw, Thomas K. Oliver, et al.. (2014). Systemic Therapy in Men With Metastatic Castration-Resistant Prostate Cancer: American Society of Clinical Oncology and Cancer Care Ontario Clinical Practice Guideline. Journal of Clinical Oncology. 32(30). 3436–3448. 165 indexed citations
3.
Vargo, John A., et al.. (2011). Dural venous sinus thrombosis in anaplastic astrocytoma following concurrent temozolomide and focal brain radiotherapy plus bevacizumab. Journal of Neuro-Oncology. 104(2). 595–598. 15 indexed citations
4.
Niechajev, Igor & James N. Frame. (2011). A Plea to Control Medical Tourism. Aesthetic Plastic Surgery. 36(1). 202–206. 6 indexed citations
5.
Frame, James N., Lawrence Rice, John R. Bartholomew, & Andrew Whelton. (2010). Rationale and design of the PREVENT-HIT study: A randomized, open-label pilot study to compare desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosis. Clinical Therapeutics. 32(4). 626–636. 14 indexed citations
6.
Boyce, Steven W., Dennis F. Bandyk, John R. Bartholomew, James N. Frame, & Lawrence Rice. (2010). A Randomized, Open-Label Pilot Study Comparing Desirudin and Argatroban in Patients With Suspected Heparin-Induced Thrombocytopenia With or Without Thrombosis: PREVENT-HIT Study. American Journal of Therapeutics. 18(1). 14–22. 24 indexed citations
7.
Frame, James N.. (2005). The Heparin-Induced Thrombocytopenia Task Force Model: Implementing Quality Improvement and Economic Outcome Initiatives. Seminars in Hematology. 42(3 Suppl 3). S28–S35. 14 indexed citations
8.
Jelić, Tomislav, et al.. (2003). Primary, Extranodal, Follicular Non-Hodgkin Lymphoma of the Gallbladder: Case Report and a Review of the Literature. Leukemia & lymphoma. 45(2). 381–387. 12 indexed citations
9.
Chute, John P., David Venzon, Paul Okunieff, et al.. (1997). Outcome of Patients With Small-Cell Lung Cancer During 20 Years of Clinical Research at the US National Cancer Institute. Mayo Clinic Proceedings. 72(10). 901–912. 24 indexed citations
10.
Shaw, Gail L., Barbara Weiffenbach, Roni T. Falk, et al.. (1997). Frequency of the variant allele CYP2D6(C) among North American Caucasian lung cancer patients and controls. Lung Cancer. 17(1). 61–68. 4 indexed citations
11.
Chute, John P., David Venzon, Paul Okunieff, et al.. (1997). Outcome of Patients With Small-Cell Lung Cancer During 20 Years of Clinical Research at the US National Cancer Institute. Mayo Clinic Proceedings. 72(10). 901–912. 34 indexed citations
12.
Chute, John P., et al.. (1996). Aplastic anemia as the sole presentation of systemic lupus erythematosus. American Journal of Hematology. 51(3). 237–239. 1 indexed citations
13.
Chute, John P., et al.. (1996). Aplastic anemia as the sole presentation of systemic lupus erythematosus. American Journal of Hematology. 51(3). 237–239. 7 indexed citations
14.
Otterson, Gregory A., Brian P. Monahan, Nancy Harold, et al.. (1996). Clinical significance of the FV:Q506 mutation in unselected oncology patients. The American Journal of Medicine. 101(4). 406–412. 38 indexed citations
15.
Johnson, Bruce E., J. R. Gray, R. Ilona Linnoila, et al.. (1996). Patients with limited-stage small-cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and vincristine.. Journal of Clinical Oncology. 14(3). 806–813. 97 indexed citations
16.
Saxena, Richa, Mary V. Relling, James N. Frame, et al.. (1994). Identification of a new variant CYP2D6 allele with a single base deletion in exon 3 and its association with the poor metabolizer phenotype. Human Molecular Genetics. 3(6). 923–926. 81 indexed citations
17.
Tribble, David R., P Church, & James N. Frame. (1993). Gastrointestinal Visceral Motor Complications of Dermatomal Herpes Zoster: Report of Two Cases and Review. Clinical Infectious Diseases. 17(3). 431–436. 31 indexed citations
18.
Frame, James N., et al.. (1993). Rhodococcus equi Causing Bacteremia in an Adult With Acute Leukemia. Southern Medical Journal. 86(2). 244–246. 12 indexed citations
19.
20.
Frame, James N., et al.. (1989). Correction of Severe Heparin-Associated Thrombocytopenia with Intravenous Immunoglobulin. Annals of Internal Medicine. 111(11). 946–947. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sidney Scudder Breakdown of academic impact, for papers by Clarence Lam Breakdown of academic impact, for papers by Finn Wesenberg Breakdown of academic impact, for papers by G. Aulagner Breakdown of academic impact, for papers by Janine Ross Breakdown of academic impact, for papers by R. Jackson Forcier Breakdown of academic impact, for papers by L. Tagliabue Breakdown of academic impact, for papers by Daryn Smith Breakdown of academic impact, for papers by John J. Stuart Breakdown of academic impact, for papers by Eleanor Kane
Rankless by CCL
2026